28
Views
1
CrossRef citations to date
0
Altmetric
Original

Chronic Renal failure: Are There Environmental and Occupational Risk Factors?

Pages 313-321 | Published online: 24 Sep 2010

References

  • Geerlins W., Tufveson G., Brunner F. P., et al. Combined repon on regular dialysis and transplantation in Europe XXI, 1990. Nephrol Dial Transplant 1991; 6: 5
  • Ritz E., Mann J., Stoeppler M. Lead and the kidney. Advances in Nephrology, J. P. Grünfeld, J. F. J. Bach, J. L. Crosnier Funck-Bretano. Year Book Medical Publishers, Chicago 1988; 241
  • Bennett W. M. Lead nephropathy. Kidney Int. 1978; 28: 212
  • Cooper W. C. Deaths from chronic renal diseaese in US battery and lead production workers. Environ. Health Perspecr 1988; 78: 61
  • Wedeen R. P., Mallik D. K., Batumen V. Detection and treatment of occupational lead nephropathy. Arch. Intern. Med. 1979; 139: 53
  • Adams R. G., Harrison J. F., Scott P. The development of cadmium-induced proteinuria, impaired renal function mid osteomalacia in alkaline battery workers. Q. J. Med. 1969; 38: 425
  • Kjellström T., Friberg L., Rahnster B. Mortality and cancer morbidity among cadmium-exposed workers. Environ. Health Perspect. 1979; 28: 199
  • Kido T., Nogawa K., Ishizaki M. Long-term observation of serum creatinine and arterial blood pH in persons with cadmium-induced renal dysfunction. Arch. Environ. Health 1990; 45: 35
  • Nishijo M., Nakagawa H., Monkawa Y. Mortality of inhabitants in an area polluted by cadmium : 15 year follow-up. Occup. Environ. Med. 1995; 52: 181
  • Nuyts GD., Van Viem E., Thys J., et al. New occupational risk factors for chronic renal failure. Lancet 1995; 346: 7
  • Stengel B., Cenee S., Limasset J. C., et al. Organic solvent exposure may aggravate the risk of glomemlar nephropathies with chronic renal failure. Int. J. Epidem. 1995; 24: 427
  • Porro A., Lomonte C., Corarelli P., et al. Chronic glomerulonephritis and exposure to solvents : a case referent study. Br. J. Indust. Med. 1992; 49: 738
  • Wedeen R. P. Occupational and environmental renal disease. Semin. Nephrol. 1997; 17: 46
  • Bombassei G. J., Kaplan A. A. The association between hydrocarbon exposure and anti-glomerular basement membrane antibody mediated disease (Goodpasture's syndrome). Am. J; Indust. Med. 1992; 21: 141
  • Bell G. V., Morgan J. M. Chronic lead ingestion and gout. Sth. Med. J. 1968; 61: 21
  • Batunan V., Landy E., Maesaka J. K., Wedeen R. P. Contribution of lead to hypertension with renal impairement. N. Engl. J. Med. 1983; 309: 17
  • Staessen I., Lauwerys R. R., Bernard A., et al. Renal function is inversely correlated with lead exposure in the general population. N. Engl. J. Med 1994; 327: 151
  • Aoshima K., Kawanishi Y., Fan J. J. Cross sectional assessment of renal function in the inhabitants of a cadmium pollured area. Ann. Clin. Lab. Sci. 1995; 25: 493
  • Vanherweghem J. L., Depierreux M., Tielemans C., et al. Rapidly progressive interstirial renal fibrosis in young women : Association with slimming Chinese herbs. Lancet 1993; 341: 387
  • Cosyns J. P., Jadoul M., Squifflet J. P., et al. Chinese herbs nephropathy : a clue to Balkan endemic nephropathy. Kidney Int. 1994; 45: 1680
  • Nolte S., Hufschmidt C., Steinhauer H., et al. Terminal renal failure caused by interstitial nephritis following mushroom poisoning by Cortinarius speciosissimus. Monatsschr. Kinderheiltk. 1987; 135: 280
  • Delpech N., Rapior S., Cozette A. P., et al. Outcome of acute renal failure caused by voluntary ingestion of Cortinarius orellanus. Presse Med. 1990; 27: 122
  • Horn S., Horrina J. H., Krejs G. J., et al. End Stage Renal Failure from mushroom poisoning with Cortinarius Orellanus; repon of four cases and review of the literature. Am. J. Kidney Dis. 1997; 30: 282
  • Godin M., Fillastre J. P., Simon P., et al. Is ochratoxin A nephrotoxic in human beings ?. Adv. Nephrol. 1996; 25: 187
  • Castegnaro M., Chernozemsky I. N., Hietnen E., et al. Are mycoroxins risk factors for endemic nephropathy and associated urothelial cancers ?. Arch. Geschwulstforsch. 1990; 60: 295
  • Maaroufi K., Achour A., Betbeder A. M., et al. Foodstuffs and human blood contamination by the mycotoxin ochratoxin A : correlation with chronic interstitial nephropathy in Tunisia. Arch. Toxicol. 1995; 69: 552
  • Spoendlin M., Moch H., Brünner W., et al. Kariomegalic interstitial nephritis further support for a distinct entity and evidence of a genetic defect. Am. J. Kidney. Dis. 1995; 25: 242
  • Simon P., Godin M., Fillastre J. P. Ochratoxin: a new environmental factor which is toxic for the kidney ?. Nephrol. Dial Transplant 1996; 11: 2389
  • Simon P., Bougault P, Boussari M., et al. Environmental risk factors in patients with chronic renal failure due to biopsy-confirmed primary, iinterstitial nephropathy, Submitted
  • Hestbech J. L., Hansen H. E., Amdisen A., et al. Chronic renal lesions following long- term treatment with lithium. Kidney Int. 1977; 12: 205
  • Tyrer S. P., Schacht R. G., McCarthy M. J., et al. The effect of lithium on renal haemodynamic function. Psychol. Med. 1983; 13: 61
  • Jensen S. B., Rickers H. Glomerular filtration rate during lithium therapy: a longitudinal study. Acta Psychiatr. Scand. 1984; 70: 235
  • Spuhler O., Zollinger H. U. Die chronsiche interstitial nephritis. Z. Klin. Med. 1953; 151: 1
  • Dubach U. C. An epidemiologic study of abuse of analgesic drugs. N. Engl. J. Med. 1991; 324: 155
  • Brunner F. P., Selwood N. H. End-stage renal failure due to analgesic nephropathy. its changing pattern and cardiovascular morality. Nephrol. Dial; Transplant 1994; 9: 1371
  • Wing A. J., Brunner F. P., Geerlings W., et al. Contribution of toxic nephropathies to end stage renal failure in Europe : a repot from the EDTA-ERA registry. Toxicol. Lett. 1989; 46: 281
  • Elseviers M. M., De Broe M. E. A long-term prospective controlled study of analgesic abuse in Belgium. Kidney Int. 1995; 48: 1912
  • Elseviers M. M., De Broe M. E. Combination analgesic involvement in the pathogenesis of analgesic nephropathy : the European perspective. Am. J. Kidney Dis. 1996; 28: S48, suppl. 1
  • Duggin G. G. Combination analgesic-induced kidney disease : the Australian experience. Am. J. Kidney Dis. 1996; 28: S39, suppl. 1
  • Bennett W. M., Henrich W. L., Stoff J. S. The renal effects of nonsteroidal anti inflammatory drugs. Am. J. Kidney Dis. 1996; 28: S56, suppl.1
  • Palestine A. G., Austin H. R., Balow J. E., et al. Renal histopathologic alterations in patients treated with cyclosporine for uveitis. N. Engl. J. Med. 1986; 314: 1293
  • Myers B. D., Ross J., Newton L., et al. Cyclosporine-associuted chronic nephropathy. N. Engl. J. Med. 1984; 311: 699
  • Whearley H. C., Daltzman M., Williams J. W., et al. Long-term effects of cyclosporine on red function in liver transplant recipients. Transplantation 1987; 43: 641
  • Dentino M., Luft R. C., Yum N. M., et al. Long term effect of cis-diamminedichloride platinum on renal function and structure in man. Cancer 1978; 41: 1274
  • Lehane D., Winston A., Gray R., et al. The effect of diuretic pretreamenr on clinical. morphological, and ultrastructural cis-platinum induced nephrotoxicity. J. Radiat. Oncol. Biol. Physics 1979; 5: 1393

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.